SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sylvester80 who wrote (1226055)5/1/2020 8:54:37 PM
From: Tenchusatsu3 Recommendations

Recommended By
Brumar89
locogringo
Mick Mørmøny

  Read Replies (2) of 1573038
 
Sly,
And that is exactly what the much larger China study found.
Holy shit, Sly. You are entitled to your own feelings, but you are not entitled to your own facts.

The Chinese study had 237 patients, while the American study had 1,060. From STAT News, the original source of the leaked Chinese study report:

statnews.com
According to the abstract, 158 patients received remdesivir and 79 patients were in the control arm; one patient in the control arm withdrew before receiving treatment.
Also, the Chinese study was terminated early. The official line was that China had a tough time finding new patients with COVID-19.

But it can be surmised that Gilead, after getting backstabbed by China with its patent filing and its blatant copying of the drug, wanted to terminate the relationship and stop any further losses with an untrustworthy partner.

Really Sly, you're doing a terrible job being a shill for the Chinese Communist Party.

Tenchusatsu
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News